Want to join the conversation?
$CPB said that for FY16 the company expects sales to change by negative 1% to 0%, unchanged from previous guidance; adjusted EBIT is expected to grow by 11-13%, up from the 10-13% reported earlier; and adjusted EPS is expected to grow by 11-13% or to be in the range of $2.93-3.00 per share, up from the 9-12% reported earlier.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?